| Product Code: ETC13384042 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Colistin Market was valued at USD 0.54 Billion in 2024 and is expected to reach USD 0.76 Billion by 2031, growing at a compound annual growth rate of 6.80% during the forecast period (2025-2031).
The global colistin market is witnessing significant growth due to the rising prevalence of multidrug-resistant bacterial infections, particularly in healthcare settings. Colistin, an antibiotic of last resort, is increasingly being used to combat these infections, driving market demand. The market is characterized by the presence of key players such as Shionogi & Co., Ltd., Sun Pharmaceutical Industries Ltd., and Meiji Seika Pharma Co., Ltd., who are investing in research and development activities to innovate new formulations and improve efficacy. Additionally, increasing awareness about the threat of antibiotic resistance and government initiatives to control the spread of such infections are further propelling market growth. However, concerns regarding the development of resistance to colistin and side effects associated with its use are challenges that may impact market expansion in the future.
The global colistin market is experiencing growth due to the increasing prevalence of multidrug-resistant bacterial infections, particularly in healthcare settings. This has led to a rise in the demand for colistin as a last-resort antibiotic treatment. Additionally, the expanding animal husbandry industry, where colistin is used as a growth promoter in livestock, is also contributing to market growth. However, concerns about colistin`s potential for antibiotic resistance and its impact on human health are driving regulatory interventions and pushing for alternatives in animal farming. Opportunities in the market lie in the development of novel formulations with improved efficacy and safety profiles, as well as strategic partnerships and collaborations to expand market presence globally. Companies investing in research and development to address these challenges are likely to succeed in this evolving market landscape.
The Global Colistin Market faces several challenges, including the emergence of colistin resistance among bacteria due to overuse and misuse of the antibiotic in both humans and animals, leading to decreased effectiveness in treating infections. Additionally, there are concerns about the potential impact of colistin residues in food products on human health and the environment. Regulatory restrictions and bans on colistin use in certain regions further hinder market growth. The development of alternative antibiotics and treatment options, as well as the need for improved stewardship practices to preserve the effectiveness of colistin, are key challenges that the market must address to ensure sustainable use and availability of this important antibiotic.
The Global Colistin Market is primarily driven by the increasing prevalence of multidrug-resistant bacterial infections, particularly in hospital settings. Colistin, as a last-resort antibiotic, is in high demand for treating infections caused by these resistant strains. Additionally, the rise in the geriatric population and the subsequent increase in chronic diseases have led to a higher incidence of infections, further boosting the demand for colistin. The market is also influenced by the growing awareness among healthcare providers about the efficacy of colistin in treating critical infections. Moreover, ongoing research and development activities aimed at improving the efficacy and safety profile of colistin are expected to drive market growth in the coming years.
Government policies related to the Global Colistin Market focus on regulating the use of colistin, an important antibiotic, to address concerns about antimicrobial resistance. Many countries have implemented restrictions on the use of colistin in animal feed to prevent the development of resistant bacteria. Additionally, regulatory bodies have been working to promote responsible use of colistin in human medicine through guidelines and surveillance programs. The overarching goal of these policies is to preserve the effectiveness of colistin as a last-resort antibiotic for treating serious infections while minimizing the risk of resistance development. Compliance with these regulations is crucial for stakeholders in the Global Colistin Market to ensure sustainable use and availability of this vital antibiotic.
The Global Colistin Market is expected to witness steady growth in the coming years, driven by the increasing prevalence of multidrug-resistant bacterial infections, particularly in healthcare settings. The rising demand for effective antibiotics to combat these infections, coupled with ongoing research and development efforts to improve the efficacy and safety of colistin-based treatments, will further fuel market expansion. Additionally, the growing awareness among healthcare professionals and policymakers regarding the urgent need to address antimicrobial resistance is likely to support market growth. However, stringent regulations related to the use of colistin due to concerns about resistance development and potential side effects may pose challenges to market players. Overall, the market is anticipated to experience moderate growth, with a focus on innovation and regulatory compliance shaping its future trajectory.
In the global Colistin market, Asia is expected to dominate due to the high prevalence of bacterial infections and limited availability of alternative antibiotics. North America follows closely behind, driven by the rising incidence of multidrug-resistant infections. Europe is also a key market, with increasing awareness about the effectiveness of Colistin in treating various bacterial strains. In the Middle East and Africa region, the market is growing steadily due to improving healthcare infrastructure and increasing investment in research and development. Latin America is witnessing moderate growth in the Colistin market, attributed to the rising healthcare expenditure and growing awareness about infectious diseases. Overall, the global Colistin market is projected to continue expanding across all regions, driven by the escalating threat of antibiotic resistance.
Global Colistin Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Colistin Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Colistin Market Revenues & Volume, 2021 & 2031F |
3.3 Global Colistin Market - Industry Life Cycle |
3.4 Global Colistin Market - Porter's Five Forces |
3.5 Global Colistin Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Colistin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Colistin Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Colistin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Colistin Market Trends |
6 Global Colistin Market, 2021 - 2031 |
6.1 Global Colistin Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Colistin Market, Revenues & Volume, By API, 2021 - 2031 |
6.1.3 Global Colistin Market, Revenues & Volume, By Premix, 2021 - 2031 |
6.1.4 Global Colistin Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Colistin Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Colistin Market, Revenues & Volume, By Pig, 2021 - 2031 |
6.2.3 Global Colistin Market, Revenues & Volume, By Chicken, 2021 - 2031 |
6.2.4 Global Colistin Market, Revenues & Volume, By Other, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Colistin Market, Overview & Analysis |
7.1 North America Colistin Market Revenues & Volume, 2021 - 2031 |
7.2 North America Colistin Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Colistin Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Colistin Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Colistin Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Colistin Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Colistin Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Colistin Market, Overview & Analysis |
8.1 Latin America (LATAM) Colistin Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Colistin Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Colistin Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Colistin Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Colistin Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Colistin Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Colistin Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Colistin Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Colistin Market, Overview & Analysis |
9.1 Asia Colistin Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Colistin Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Colistin Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Colistin Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Colistin Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Colistin Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Colistin Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Colistin Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Colistin Market, Overview & Analysis |
10.1 Africa Colistin Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Colistin Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Colistin Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Colistin Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Colistin Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Colistin Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Colistin Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Colistin Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Colistin Market, Overview & Analysis |
11.1 Europe Colistin Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Colistin Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Colistin Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Colistin Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Colistin Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Colistin Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Colistin Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Colistin Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Colistin Market, Overview & Analysis |
12.1 Middle East Colistin Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Colistin Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Colistin Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Colistin Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Colistin Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Colistin Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Colistin Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Colistin Market Key Performance Indicators |
14 Global Colistin Market - Export/Import By Countries Assessment |
15 Global Colistin Market - Opportunity Assessment |
15.1 Global Colistin Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Colistin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Colistin Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Colistin Market - Competitive Landscape |
16.1 Global Colistin Market Revenue Share, By Companies, 2024 |
16.2 Global Colistin Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |